Radiation therapy and IRreversible electroporation for intermediate risk prostate cancer (RTIRE)
Abstract Introduction Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE) is a phase II clinical trial testing combination of radiation therapy and irreversible electroporation for intermediate risk prostate cancer Background PCa is the most common non-cu...
| Published in: | BMC Urology |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-07-01
|
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12894-024-01506-8 |
